Dhainaut et al., J.Med.Chem. vol. 35, pp. 2481-2496 (1992).* |
Suzuki et al., J.Med.Chem vol. 40, pp. 2047-2052 (1997).* |
Kuzmich and Tew, “Detoxification Mechanisms and Tumor Cell Resistance to Anticancer Drugs,” Medical Research Reviews, vol. 11, No. 2, pp. 185-217 (217). |
Georges, Sharom, and Ling, “Multidrug Resistance and Chemosensitization: Therapeutic Implications for Cancer Chemotherapy,” Advances in Pharmacology, vol. 1, pp. 185-200 (1990). |
Berge, Bighley, and Monkhouse, “Pharmaceutical Salts,” J. Pharm. Sci., vol. 66, No. 1, pp. 1-19 (1997). |
Section XIII, “Chemotherapy of Neoplastic Diseases” in Goodman and Gilman's The Pharmacological Basis of Therapeutics, Seventh Edition, pp. 1240-1306 (1985). |
Childs, Brown, Anet, and Winstein, “A Dibenzohomotropylium Ion,” J. Am. Chem. Soc., vol. 94, No. 7, pp. 2175-2183 (1972). |
Berti, J. Org. Chem., vol. 22, p. 230 (1957). |
Looker, J. Org. Chem., vol. 33, No. 3, pp. 1304-1306 (1968). |
Dykstra, Minielli, Lawson, J. Med. Chem. vol. 16, No. 9, pp. 1015-1020 (1973). |
Bugle and Osteryoung J. Org. Chem., vol. 44, No. 10, pp. 1719-1720 (1979). |
Ashcroft and Joule, Heterocycles, vol. 16, No. 11, pp. 1883-1887 (1981). |
Coyne and Cusic, J. Med. Chem., vol. 17, No. 1, pp. 72-75 (1974). |
Florence and Attwood, Physicochemical Principles of Pharmacy, 2nd Ed., Chapman and Hall, New York, NY 1988, pp. 23-46. |
March, J. Ad. Org. Chem., 3rd edition, 1985, John Wiley and sons, New York (cover page and table of contents only provided). |
Larock, Comprehensive Organic Transformations, 1989, VCH publisher, New York cover page and table of contents, only provided. |
Remington's Pharm. Sci., 17th edition, 1985 table of contents, only provided. |